Form 4 for ACRV Acrivon Therapeutics, Inc.
Accepted 2026-01-21 00:00:00 ET · period of report 2026-01-17 · accession 0000905148-26-000281 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-21 | 2026-01-17 | ACRV | Miller Mary | CLO | F - Tax | $1.98 | -659 | 33.9K | -2% | -$1,305 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-17 | F | D | 659 | $1.98 | 33,896 | D | — | — |